World Investment Advisors
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1652594
SANTA BARBARA, CA
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$326,855
+$93,862 QoQ
Shares Held
4,010
+7.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#335
of 497 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026World Investment Advisors holds $5,381,853 across 15 Biotechnology names. ARWR ranks #8 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GERN |
Geron Corp
|
1,033,779 | $1,323,237 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,866 | $926,898 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,301 | $577,577 | |
| 4 | MRNA |
Moderna, Inc.
|
6,784 | $475,083 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
737 | $459,548 | |
| 6 | INCY |
Incyte Corp
|
3,471 | $393,472 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
24,616 | $363,332 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
4,010 | $326,855 |
All Filings in ARWR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,855 | 4,010 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $232,993 | 3,716 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $729,426 | 10,987 | Shares | Sole | 2026-03-13 | |
| 2025-09-30 | $475,168 | 13,777 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $217,676 | 13,777 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $236,416 | 18,557 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $352,631 | 18,757 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $370,586 | 19,132 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $479,047 | 18,432 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $221,707 | 7,752 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $511,234 | 16,707 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $396,520 | 14,757 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $533,901 | 14,972 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $509,549 | 20,061 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $836,590 | 20,626 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $913,039 | 27,626 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,043,835 | 29,646 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,382,045 | 30,051 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,968,645 | 29,693 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,598,894 | 25,611 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $823,644 | 9,945 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $570,929 | 8,610 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||